İstanbul Journal of Pharmacy

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/IstanbulJPharm.2023.1180952   IUP :10.26650/IstanbulJPharm.2023.1180952    Full Text (PDF)

Evaluation of disease and medication knowledge levels of diabetic patients

Rashida Muhammad Umar, Büşra Nur Çattık, Selim Aslan

Background and Aims: Diabetes mellitus is a public health problem with a significant economic burden to society. Patient attitude is a significant determinant of adherence and clinical outcomes. We aimed to evaluate the disease and medication knowledge level of diabetic patients and possible patient-related predictive factors.

Methods: Adult diabetic patients were included in the study. Patients’ demographic and health-related data were collected using a pre-prepared form. Two questionnaires, KAP knowledge tool and Medication Assessment tool were used to assess the disease and medication knowledge levels of patients.

Results: The mean age of 159 patients was 54.44±12.24 years. The disease and medication knowledge scores were high with an average of 13.9±1.74 and 5.26±0.53, respectively. Higher scores were linked to being male (p=0.042; p=0.007) and higher educational status (p<0.001; p=0.006). Lower scores were recorded in patients with comorbidities (p=0.002; p<0.001), older patients (p<0.001), longer disease duration (p<0.001; p=0.009), longer antidiabetic drug use (p<0.001; p=0.009) and using more drugs (p=0.002; p=0.006). None of the patients could mention any possible side effects of their medications.

Conclusion: It can be deduced that patient-related factors are significant predictors of patients’ disease and medication knowledge. Patient-specific education in addition to rational pharmacological intervention is necessary to achieve better clinical outcomes.

Keywords: Diabetes mellitus, disease knowledge, medication knowledge, patient factors

PDF View

References

  • Abdulrhim, S., Sankaralingam, S., Ibrahim, M. I. M., and Awaisu, A. (2020). The Impact of Pharmacist Care on Diabetes Outcomes in Primary Care Settings: An Umbrella Review of Published System-atic Reviews. Primary Care Diabetes, 14(5), 393-400. google scholar
  • Akin, A. I. (2013). Quality Of Life, Illness Knowledge Level, Illness Perception And Style Of Coping With Stress In People (Masters thesis, Okan University, Istanbul). Retrieved from http://earsiv. okan.edu.tr/xmlui/browse?type=author&value=Asena+%C4%B0 rem%2C+AKIN google scholar
  • Al-Adsani, A.M.S., Moussa, M.A.A., Al-Jasem, L.I., Abdella, N.A., Al-Hamad, N.M. (2009). The Level and Determinants of Diabetes Knowledge in Kuwaiti Adults with Type 2 Diabetes. Diabetes and Metabolism, 35(2), 121-28. google scholar
  • Albright, T. L., M. Parchman, and S. K. Burge. (2001). Predictors of Self-Care Behavior in Adults with Type 2 Diabetes: An RRNeST Study. Family Medicine, 33(5), 354-60. google scholar
  • American Diabetes Association Professional Practice Commit-tee (2022). Standards of Medical Care in Diabetes. Diabetes Care; 45(Suppl. 1), 144-S174 google scholar
  • Brown, Marie T., and Jennifer K. Bussell. (2011). Medication Adher-ence: WHO Cares? Mayo Clinic Proceedings, 86(4), 304-14. google scholar
  • Bukhsh, A., Khan, T.M., Nawaz, M.S., Ahmed, H. S., Chan, K. G., Lee, L., and Goh, B. (2018). Association of Diabetes-Related Self-Care Activities with Glycemic Control of Patients with Type 2 Diabetes in Pakistan. Patient Preference and Adherence, 12, 2437-47. google scholar
  • Bukhsh, A., Khan, T.M., Nawaz, M.S., Ahmed, H. S., Chan, K. G., and Goh, B. (2019). Association of Diabetes Knowledge with Glyce-mic Control and Self-Care Practices among Pakistani People with Type 2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obe-sity: Targets and Therapy, 12, 1409-17. google scholar
  • Gast, Alina, and Tim Mathes. (2019). Medication Adherence Influ-encing Factors - An (Updated) Overview of Systematic Reviews. Systematic Reviews, 8(1), 1-17. google scholar
  • Guler, N., and Oguz, S. (2011). The Spoken Knowledge of Low Literacy in Patients with Diabetes. Diabetes Research and Clinical Practice, 92(2), 238-43. google scholar
  • He, X., and Wharrad. H.J. (2007). Diabetes Knowledge and Glyce-mic Control among Chinese People with Type 2 Diabetes. Inter-national Nursing Review, 54(3), 280-87. google scholar
  • International Diabetes Federation (2019). IDF Diabetes Atlas 9th. google scholar
  • Korcegez, E.I., Sancar, M., and Demirkan, K. (2017). Effect of a Pharma-cist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial. Journal of Managed Care & Specialty Pharmacy, 23(5), 573-582 google scholar
  • Milosavljevic, A., Aspden, T. and Harrison, J. (2018). Community Pharmacist-Led Interventions and Their Impact on Patients’ Medi-cation Adherence and Other Health Outcomes: A Systematic Review. International Journal of Pharmacy Practice, 26(5), 387-97. google scholar
  • Muhammad Haskani, N.H., Goh, H.P., Wee, D.V.T., Hermansyah, A., Goh, K.W., Ming, L.C. (2022). Medication Knowledge and Adher-ence in Type 2 Diabetes Mellitus Patients in Brunei Darussalam: A Pioneer Study in Brunei Darussalam. International Journal of Envi-ronmental Research and Public Health, 19(12), 7470. google scholar
  • Newman, T.V., San-Juan-Rodriguez, A., Parekh, N., Swart, E.C.S, Klein-Fedyshin, M., Shrank, W.H., Hernandez, I. (2020). Impact of Community Pharmacist-Led Interventions in Chronic Disease Management on Clinical, Utilization, and Economic Outcomes: An Umbrella Review. Research in Social and Administrative Phar-macy, 16(9), 1155-65. google scholar
  • Okuyan, B., Sancar, M. and Izzettin, F.V. (2013). Assessment of Med-ication Knowledge and Adherence among Patients under Oral Chronic Medication Treatment in Community Pharmacy Settings. Pharmacoepidemiology and Drug Safety, 22(2), 209-14 google scholar
  • Quinton, A., Lewis, P., Ali, P., Morgan, C. and Bertelli, G. (2013). A Comparison of Measured and Estimated Glomerular Filtration Rate for Carboplatin Dose Calculation in Stage I Testicular Semi-noma. Medical Oncology, 30(3) :661. google scholar
  • World Health Organization. (2003). Adherence to long-term ther-apies: evidence for action. World Health Organization. https:// apps.who.int/iris/handle/10665/42682 google scholar
  • Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Un-win, N.,... Williams, R., (2019). Global and Regional Diabetes Prev-alence Estimates for 2019 and Projections for 2030 and 2045: Re-sults from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 157, 107843. google scholar
  • Satman, I., Omer, B. Tutuncu, Y. Kalaca, S., Gedik, S., Dinccag, N., .Tuomiletho, J. (2013). Twelve-Year Trends in the Prevalence and Risk Factors of Diabetes and Prediabetes in Turkish Adults. Euro-pean Journal of Epidemiology, 28(2), 169-80. google scholar
  • Shrivastava, S. R., Shrivastava, P.S., and Ramasamy, J. (2013). Role of Self-Care in Management of Diabetes Mellitus. Journal of Diabetes and Metabolic Disorders, 12(14), 1-5. google scholar
  • Sweileh, W.M., Zyoud, S.H., Abu Nab’a, R.J. Deleq, M.I., Enaia, M.I., Nassar, S.M., Al-Jabi, S.W. (2014). Influence of Patients’ Disease Knowledge and Beliefs about Medicines on Medication Adher-ence: Findings from a Cross-Sectional Survey among Patients with Type 2 Diabetes Mellitus in Palestine. BMC Public Health, 14(1), 1-8. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Umar, R.M., Çattık, B.N., & Aslan, S. (2023). Evaluation of disease and medication knowledge levels of diabetic patients. İstanbul Journal of Pharmacy, 53(2), 103-109. https://doi.org/10.26650/IstanbulJPharm.2023.1180952


AMA

Umar R M, Çattık B N, Aslan S. Evaluation of disease and medication knowledge levels of diabetic patients. İstanbul Journal of Pharmacy. 2023;53(2):103-109. https://doi.org/10.26650/IstanbulJPharm.2023.1180952


ABNT

Umar, R.M.; Çattık, B.N.; Aslan, S. Evaluation of disease and medication knowledge levels of diabetic patients. İstanbul Journal of Pharmacy, [Publisher Location], v. 53, n. 2, p. 103-109, 2023.


Chicago: Author-Date Style

Umar, Rashida Muhammad, and Büşra Nur Çattık and Selim Aslan. 2023. “Evaluation of disease and medication knowledge levels of diabetic patients.” İstanbul Journal of Pharmacy 53, no. 2: 103-109. https://doi.org/10.26650/IstanbulJPharm.2023.1180952


Chicago: Humanities Style

Umar, Rashida Muhammad, and Büşra Nur Çattık and Selim Aslan. “Evaluation of disease and medication knowledge levels of diabetic patients.” İstanbul Journal of Pharmacy 53, no. 2 (Sep. 2024): 103-109. https://doi.org/10.26650/IstanbulJPharm.2023.1180952


Harvard: Australian Style

Umar, RM & Çattık, BN & Aslan, S 2023, 'Evaluation of disease and medication knowledge levels of diabetic patients', İstanbul Journal of Pharmacy, vol. 53, no. 2, pp. 103-109, viewed 16 Sep. 2024, https://doi.org/10.26650/IstanbulJPharm.2023.1180952


Harvard: Author-Date Style

Umar, R.M. and Çattık, B.N. and Aslan, S. (2023) ‘Evaluation of disease and medication knowledge levels of diabetic patients’, İstanbul Journal of Pharmacy, 53(2), pp. 103-109. https://doi.org/10.26650/IstanbulJPharm.2023.1180952 (16 Sep. 2024).


MLA

Umar, Rashida Muhammad, and Büşra Nur Çattık and Selim Aslan. “Evaluation of disease and medication knowledge levels of diabetic patients.” İstanbul Journal of Pharmacy, vol. 53, no. 2, 2023, pp. 103-109. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2023.1180952


Vancouver

Umar RM, Çattık BN, Aslan S. Evaluation of disease and medication knowledge levels of diabetic patients. İstanbul Journal of Pharmacy [Internet]. 16 Sep. 2024 [cited 16 Sep. 2024];53(2):103-109. Available from: https://doi.org/10.26650/IstanbulJPharm.2023.1180952 doi: 10.26650/IstanbulJPharm.2023.1180952


ISNAD

Umar, RashidaMuhammad - Çattık, BüşraNur - Aslan, Selim. “Evaluation of disease and medication knowledge levels of diabetic patients”. İstanbul Journal of Pharmacy 53/2 (Sep. 2024): 103-109. https://doi.org/10.26650/IstanbulJPharm.2023.1180952



TIMELINE


Submitted27.09.2022
Accepted23.05.2023
Published Online28.08.2023

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.